Evaluation of Blood Glucose Monitoring Systems

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Diabetes
Interventions
DEVICE

Contour® NEXT LINK BGMS

Study staff performed Blood Glucose (BG) tests with capillary fingerstick blood collected from subjects with and without diabetes (up to 10% of subjects without diabetes were included). Performance of Contour® NEXT LINK BGMS was evaluated across the glucose range of the BGMSs. All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).

DEVICE

OneTouch® UltraLink® BGMS

Study staff performed Blood Glucose (BG) tests with capillary fingerstick blood collected from subjects with and without diabetes (up to 10% of subjects without diabetes were included). Performance of OneTouch® UltraLink® BGMS was evaluated across the glucose range of the BGMSs. All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).

DEVICE

Nova Max Link® BGMS

Study staff performed Blood Glucose (BG) tests with capillary fingerstick blood collected from subjects with and without diabetes (up to 10% of subjects without diabetes were included). Performance of Nova Max Link® BGMS was evaluated across the glucose range of the BGMSs. All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).

Trial Locations (1)

46544

Bayer HealthCare LLC, Diabetes Care, Mishawaka

Sponsors
All Listed Sponsors
lead

Ascensia Diabetes Care

INDUSTRY

NCT01699763 - Evaluation of Blood Glucose Monitoring Systems | Biotech Hunter | Biotech Hunter